9-135624443-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_182974.3(GLT6D1):āc.485T>Cā(p.Ile162Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000564 in 1,614,016 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_182974.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GLT6D1 | NM_182974.3 | c.485T>C | p.Ile162Thr | missense_variant | 5/5 | ENST00000371763.6 | NP_892019.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GLT6D1 | ENST00000371763.6 | c.485T>C | p.Ile162Thr | missense_variant | 5/5 | 1 | NM_182974.3 | ENSP00000360829.1 |
Frequencies
GnomAD3 genomes AF: 0.000276 AC: 42AN: 152156Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000762 AC: 19AN: 249480Hom.: 0 AF XY: 0.0000443 AC XY: 6AN XY: 135372
GnomAD4 exome AF: 0.0000335 AC: 49AN: 1461860Hom.: 0 Cov.: 33 AF XY: 0.0000220 AC XY: 16AN XY: 727224
GnomAD4 genome AF: 0.000276 AC: 42AN: 152156Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74316
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2024 | The c.485T>C (p.I162T) alteration is located in exon 5 (coding exon 4) of the GLT6D1 gene. This alteration results from a T to C substitution at nucleotide position 485, causing the isoleucine (I) at amino acid position 162 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at